Evidence map›Paper›PMID 39853109›Full record

ArticleBriefings in bioinformatics2024

Identify potential drug candidates within a high-quality compound search space.

Xiaoqing Ru, Shulin Zhao, Quan Zou, Lifeng Xu

Abstract read
In one paragraph

Article in Briefings in bioinformatics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xiaoqing RuThe Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, No. 100, Minjiang Avenue, Smart New Town, Quzhou, Zhejiang Province, 324000, China.ORCID 0000-0002-2968-6435
Shulin ZhaoThe Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, No. 100, Minjiang Avenue, Smart New Town, Quzhou, Zhejiang Province, 324000, China.
Quan ZouYangtze Delta Region Institute (Quzhou), University of Electronic Science and Technology of China, No. 1, Chengdian Road, Kecheng District, Quzhou, Zhejiang Province, 324003, China.ORCID 0000-0001-6406-1142
Lifeng XuThe Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, No. 100, Minjiang Avenue, Smart New Town, Quzhou, Zhejiang Province, 324000, China.

Funding

Key Science and Technology Research Projects of Quzhou 2022K50Municipal Government of Quzhou 2023D036National Key R&D Program of China 2022ZD0117700National Natural Science Foundation of China 32470693Natural Science Foundation of Zhejiang Provincial LGF22G010009
6 · The paper itself

Abstract

The identification of potential effective drug candidates is a fundamental step in new drug discovery, with profound implications for pharmaceutical research and the healthcare sector. While many computational methods have been developed for such predictions and have yielded promising results, two challenges persist: (i) The cold start problem of new drugs, which increases the difficulty of prediction due to lack of historical data or prior knowledge. (ii) The vastness of the compound search space for potential drug candidates. In this study, we present a promising method that not only enhances the accuracy of identifying potential novel drug candidates but also refines the search space. Drawing inspiration from solutions to the cold start problem in recommender systems, we apply 'learning to rank' techniques to the field of new drug discovery. Furthermore, we propose using three similarity metrics to condense the compound search space into compact yet high-quality spaces, allowing for more efficient screening of potential drug candidates. Experimental results from two widely used datasets demonstrate that our method outperforms other state-of-the-art approaches in the new drug cold-start scenario. Additionally, we have verified that it is feasible to identify potential drug candidates within these high-quality compound search spaces. To our knowledge, this study is the first to address drug cold-start problem in such a confined space, potentially providing valuable insights and guidance for drug screening.

Indexed as

Computational BiologyDrug DiscoveryAlgorithmsHumansPharmaceutical PreparationsPharmaceutical Preparationsa confined compound search spacenew drug cold-start scenariopotential drug candidates screening

Identifiers

PMID39853109
PMCPMC11758506

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.